The inhibitors all demonstrated potent chemical and structural interactions with viral proteins critical to the virus's ability to proliferate, according to the study published in the journal Cell Research.
The first product is expected to be launched shortly, while approvals for the remaining are expected in the next 12-18 months, Caplin Point Laboratories said in a BSE filing.
Sinovac said the study, which will be done in partnership with Brazilian vaccine producer the Instituto Butantan, would recruit nearly 9,000 healthcare professionals working in COVID-19 specialised facilities and start this month.
Clinical trials of the indigenous COVID-19 COVAXIN may be delayed further as multiple institutes, which are selected to hold these trials, still evaluating the process.
Kannan said the occupancy rate in Vistara flights has been on an average between 50 to 60 percent since the domestic passenger services resumed on May 25.
With 2,11,987 COVID-19 cases, Maharashtra has reported the highest number of infections, followed by Tamil Nadu (1,14,978), and Delhi (1,00,823).
Coronavirus India LIVE Updates: Total confirmed cases in India have risen to 7.19 lakh.
The government also said that the national positivity rate, percentage of samples testing coronavirus positive from the total number of samples, has also reduced and now stands at 6.73 percent.
The trial, run jointly with the National Institute of Allergy and Infectious Diseases (NIAID), would test the therapy's ability to prevent infection in those who have had close exposure to a COVID-19 patient.
The suspected bubonic plague case was reported on July 4 by a hospital in Chinese city of Bayannur. The local health authority announced that the warning period will continue until the end of 2020.
While Cipla's drug is yet to be available in the market, Hetero's initial supply of 20,000 vials is nearly exhausted.
The Drug Controller General of India (DCGI) approved Mylan's remdesivir version, to be called Desrem, for the treatment of suspected or laboratory confirmed severe incidences of COVID-19 in adults and children, the company said in a statement.
Antigen tests are a relatively new type of test for COVID-19 that work by scanning for proteins that can be found on or inside a virus.
According to the ICMR, a total of 1,00,04,101 samples have been tested till 11 am on July 6
Addressing an online media briefing, the chief minister said that there has been a spike in demand for plasma over the past 4-5 days, after the opening of a plasma bank in Delhi.
A single-day jump of 24,248 COVID-19 cases took India's tally close to the 7-lakh mark on Monday, while the death toll due to the disease climbed to 19,693 with 425 new fatalities, according to the Union Health Ministry.
Bubonic plague, also known as the 'Black Death', caused more than 50 million deaths in Europe in the 14th century.
The Science and Technology ministry edited a press release to remove a sentence that suggested a vaccine against COVID-19 is "unlikely to be ready for mass use before 2021".
Reports from hospitals and researchers suggest that about two-thirds to three-fourths of coronavirus patients in ICUs have experienced it in various ways. Some have “hyperactive delirium”
With over 2.06 lakh COVID-19 cases, Maharashtra has reported the highest number of infections, followed by Tamil Nadu (1,11,151), Delhi (99,444).
The Indian Council of Medical Research has said it aims to complete the indigenous COVID-19 vaccine’s clinical trials as soon as possible, and that it has not set August 15 as a deadline.
Coronavirus India highlights: Total confirmed cases in India have risen to 6.97 lakh. India’s recovery rate stands at 60.9 percent.
The 'COVID-19 War Room', which is being set up at the Delhi Secretariat, will be manned by around 25 experts.
The therapeutic, described in the journal Cell Reports, is called TAT CARMIL1, and is actually a combination of two naturally occurring small proteins, or peptides.
Vaccine experts raised serious concerns, calling the timelines unprecendented and unrealistic.